*Correspondence: Wu Yang, [email protected] Xie, [email protected] This article was submitted to Molecular Signalling and Pathways, a section of the journal Frontiers in Molecular Neuroscience Disclaimer All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers
UQCRC1 is a newly identified PD-causing gene that is clinically characterized by autosomal dominant late-onset parkinsonism with polyneuropathy ( UQCRC1 encodes the mitochondrial ubiquinol-cyt c reductase core protein 1 (UQCRC1), which is a core subunit of cIII
Ltd., Japan-based Global Specialty Pharmaceutical Company , announced a joint research and organizational collaboration with School of Life Science and Technology and Tokyo Institute of Technology for drug discovery technology
Gim thm nm, loi b tn nhang, thm mn, u mu da,